Mounjaro Could Reduce Heart Attack Risks for Diabetes Patients, Study Says A new study published in The BMJ suggests that the diabetes medication Mounjaro could reduce the risk of heart attacks in patients with type 2 diabetes and heart disease by as much as 33%.
This finding is based on data from a clinical trial conducted in the United States. At first glance, these results seem too good to be true.
However, closer examination of the data reveals promising trends: Mounjaro patients experienced fewer heart attacks, lower hospital admission rates due to infections, and even fewer deaths from any cause compared to those taking sitagliptin, a different diabetes medication.